These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22887003)

  • 21. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic Contrast-Enhanced MRI Parameters as Biomarkers in Assessing Head and Neck Lesions After Chemoradiotherapy Using a Wide-Bore 3 Tesla Scanner.
    Lerant G; Sarkozy P; Takacsi-Nagy Z; Polony G; Tamas L; Toth E; Boer A; Javor L; Godeny M
    Pathol Oncol Res; 2015 Sep; 21(4):1091-9. PubMed ID: 25920367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced MR in the diagnosis of lympho-associated benign and malignant lesions in the parotid gland.
    Zhu L; Zhang C; Hua Y; Yang J; Yu Q; Tao X; Zheng J
    Dentomaxillofac Radiol; 2016; 45(4):20150343. PubMed ID: 26846712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of acute benign and malignant vertebral body fractures using dynamic contrast-enhanced MRI.
    Geith T; Biffar A; Schmidt G; Sourbron S; Dürr HR; Reiser M; Baur-Melnyk A
    AJR Am J Roentgenol; 2013 Jun; 200(6):W635-43. PubMed ID: 23701095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
    van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
    AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-sectional imaging combined with 3D-MR angiography (3D-MRA): diagnostic tool for preoperative vascular assessment of head and neck tumors.
    Sadick M; Sadick H; Hörmann K; Düber C; Diehl SJ
    Onkologie; 2005 Oct; 28(10):477-81. PubMed ID: 16160396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI of soft-tissue tumors: fast STIR sequence as substitute for T1-weighted fat-suppressed contrast-enhanced spin-echo sequence.
    Tokuda O; Harada Y; Matsunaga N
    AJR Am J Roentgenol; 2009 Dec; 193(6):1607-14. PubMed ID: 19933655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of tumor blood flow in breast tumors with T1-dynamic contrast-enhanced MR imaging: impact of dose reduction and the use of a prebolus technique on diagnostic efficacy.
    Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
    J Magn Reson Imaging; 2010 Mar; 31(3):556-61. PubMed ID: 20187197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
    Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of dynamic contrast-enhanced MRI for thyroid tumors.
    Yuan Y; Yue XH; Tao XF
    Eur J Radiol; 2012 Nov; 81(11):3313-8. PubMed ID: 22608396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
    Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
    Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.